Saturday, August 16, 2014

JUST AS YOU THOUGHT YOU HAVE SEEN ALL ABOUT AVASTIN!

BEVACIZUMAB HAS BEEN APPROVED FOR METASTATIC CERVICAL CANCER IN COMBINATION WITH TOPOTECAN TAXOL AND CISPLATIN BECAUSE OF INCREASE IN OVERALL SURVIVAL...AND THE FDA APPROVED!
THE POWER OF VGEF IS ONCE AGAIN DEMONSTRATED...
Bevacizumab for Advanced Cervical Cancer Approved by FDA - See more at: http://www.targetedonc.com/articles/Bevacizumab-for-Advanced-Cervical-Cancer-Approved?utm_source=Informz&utm_medium=Targeted+Onc&utm_campaign=Targeted+Breaking+News+8%2F14%2F14&utm_term=Targeted+Breaking+News+8%2F14%2F14#sthash.6xXgjV1K.dpuf
Bevacizumab for Advanced Cervical Cancer Approved by FDA - See more at: http://www.targetedonc.com/articles/Bevacizumab-for-Advanced-Cervical-Cancer-Approved?utm_source=Informz&utm_medium=Targeted+Onc&utm_campaign=Targeted+Breaking+News+8%2F14%2F14&utm_term=Targeted+Breaking+News+8%2F14%2F14#sthash.6xXgjV1K.dpuf
Post a Comment